Biogen Inc
NASDAQ:BIIB

Watchlist Manager
Biogen Inc Logo
Biogen Inc
NASDAQ:BIIB
Watchlist
Price: 146.47 USD -0.62% Market Closed
Market Cap: 21.3B USD
Have any thoughts about
Biogen Inc?
Write Note

Revenue Breakdown

Breakdown by Geography
Biogen Inc

Not Available

Breakdown by Segments
Biogen Inc

Total Revenue: 9.8B USD
100%
Product Revenue, Net: 7.2B USD
73.7%
Subtotal: Multiple Sclerosis: 4.7B USD
47.4%
Tysabri: 1.9B USD
19.1%
Subtotal: Rare Disease: 1.8B USD
18.3%
Spinraza: 1.7B USD
17.7%
Revenue From Anti-Cd20 Therapeutic Programs: 1.7B USD
17.2%
Total Fumarate: 1.6B USD
16.2%
Royalty Revenue On Sales Of Ocrevus: 1.3B USD
12.9%
Total Interferon: 1.1B USD
11.2%
Tecfidera: 1B USD
10.3%
Contract Manufacturing, Royalty And Other Rev...: 899.3m USD
9.1%
Contract Manufacturing Revenue: 848.2m USD
8.6%
Avonex: 811m USD
8.2%
Subtotal: Biosimilars: 770m USD
7.8%
Vumerity: 576.3m USD
5.9%
Benepali: 438.8m USD
4.5%
Plegridy: 294.7m USD
3%
Imraldi: 222.1m USD
2.3%
Fampyra: 90.5m USD
0.9%
Flixabi: 77.4m USD
0.8%
Completed Technology For Skyclarys (United St...: 55.9m USD
0.6%
Royalty And Other Revenue: 51.1m USD
0.5%
Byooviz: 31.7m USD
0.3%
Other: 11.8m USD
0.1%
Qalsody: 5.9m USD
0.1%
Show More
Show Less

See Also

Discover More